I have resorted to reversed phase HPLC in order to monitor the decay of several pharmaceuticals during the application of Advanced Oxidation Processes (ozonation or electrochemical processes). So, this analytical technique allows me to carry out kinetic studies on the degradation of these products. Also the concentration of arising aromatic degradation intermediates was monitored using reverse phase HPLC.
| compound |
reverse phase HPLC Analysis |
|

paracetamol
|
Phenomenex Luna C18 5 μm (250 mm x 4.6 mm i.d.)
Buffer KH2PO4 0.1 M + (tBu)4NHSO4 0.1 M + NaOH (until attaining pH 7.2) – ACN (70:30 v/v)
0.8 mL min-1, room temperature.
|
|

hydroquinone
|
Phenomenex Luna C18 5 μm (250 mm x 4.6 mm i.d.)
Buffer KH2PO4 0.1 M + (tBu)4NHSO4 0.1 M + NaOH (until attaining pH 7.2) – ACN (70:30 v/v)
0.8 mL min-1, room temperature.
|
|

p-benzoquinone
|
Phenomenex Luna C18 5 μm (250 mm x 4.6 mm i.d.)
Buffer KH2PO4 0.1 M + (tBu)4NHSO4 0.1 M + NaOH (until attaining pH 7.2) – ACN (70:30 v/v)
0.8 mL min-1, room temperature.
|
|

chloroxylenol
|
Thermo ODS hypersil 5 μm (150 mm x 3 mm i.d.)
Buffer NH4H2PO4 / H3PO4 0.015 M (pH 3.0) – ACN (50:50 v/v)
1.0 mL min-1, room temperature.
|
|

2,6-dimethyl-p-benzoquinone
|
Thermo ODS hypersil 5 μm (150 mm x 3 mm i.d.)
Buffer NH4H2PO4 / H3PO4 0.015 M (pH 3.0) – ACN (50:50 v/v)
1.0 mL min-1, room temperature.
|
|

ibuprofen
|
Thermo ODS hypersil 5 μm (150 mm x 3 mm i.d.)
Buffer NH4H2PO4 / H3PO4 0.015 M (pH 3.0) – ACN (50:50 v/v)
1.0 mL min-1, room temperature.
|
|

4-isobutylacetophenone
|
Thermo ODS hypersil 5 μm (150 mm x 3 mm i.d.)
Buffer NH4H2PO4 / H3PO4 0.015 M (pH 3.0) – ACN (50:50 v/v)
1.0 mL min-1, room temperature.
|
|

diclofenac
|
Thermo ODS hypersil 5 μm (150 mm x 3 mm i.d.)
Buffer NH4H2PO4 / H3PO4 0.015 M (pH 3.0) – ACN (50:50 v/v)
1.0 mL min-1, room temperature.
|
|

2,6-dichloroaniline
|
Thermo ODS hypersil 5 μm (150 mm x 3 mm i.d.)
Buffer NH4H2PO4 / H3PO4 0.015 M (pH 3.0) – ACN (50:50 v/v)
1.0 mL min-1, room temperature.
|